Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Zinc Finger and BTB Domain Containing 38 (ZBTB38) Peptid

ZBTB38 Reaktivität: Human Wirt: Synthetic BP, WB, IHC
Produktnummer ABIN986344

Kurzübersicht für Zinc Finger and BTB Domain Containing 38 (ZBTB38) Peptid (ABIN986344)

Target

ZBTB38 (Zinc Finger and BTB Domain Containing 38 (ZBTB38))

Spezies

Human

Quelle

  • 4
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-ZBTB38 antibody (Catalog #: ARP40114_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Aufreinigung

    Purified
  • Applikationshinweise

    Each Investigator should determine their own optimal working dilution for specific applications.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Konzentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handhabung

    Avoid repeated freeze-thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    ZBTB38 (Zinc Finger and BTB Domain Containing 38 (ZBTB38))

    Hintergrund

    ZBTB38 contains 10 C2H2-type zinc fingers and 1 BTB (POZ) domain. ZBTB38 acts as a transcriptional activator and may be involved in the differentiation and/or survival of late postmitotic neurons.

    Alias Symbols: CIBZ, ZNF921

    Protein Interaction Partner: RBBP6

    Protein Size: 1192

    Molekulargewicht

    131 kDa

    Gen-ID

    253461

    NCBI Accession

    XM_001133510, XP_001133510

    UniProt

    Q8NAP3
Sie sind hier:
Chat with us!